New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies. (Q53401128)
Jump to navigation
Jump to search
scientific article published in December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies. |
scientific article published in December 2015 |
Statements
New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies. (English)
1 reference
Christelle Foucher
1 reference
Patrick Aubonnet
1 reference
Petr Reichert
1 reference
Mario Berli
1 reference
Axel Schaeffer
1 reference
Cesar Gonzalo Calvo Vargas
1 reference
Anna Lochocka
1 reference
Dmitry Belenky
1 reference
Hans-Friedrich Koch
1 reference
Cholib study Investigators
1 reference
1 December 2015
1 reference
33
1 reference
329-337
1 reference
6
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference